Domestic drugs reach record high share of public procurements in Russia

The share of domestic drugs in the public procurements in Russia has reached record figures for the last four years and currently continues to grow, according to recent statistics, published by the Russian Ministry of Health and statements of some local analysts in the field of pharmaceutics.

The published statistics show that the share of domestically-made drugs in the segment of public procurements in Russia during the period of 2014–2018 grew from 20% to 35% in value terms, reports The Pharma Letter’s local correspondent.

According to data from DSM Group, in value terms these figures grew from 66.5 billion roubles ($1 billion) in 2014 to 148.7 billion roubles in 2018.